A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Dry Eye

In brief

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Key facts

Study ID

NCT06296966

Run by

Vanda Pharmaceuticals

People needed

40

Starts

2024-02-29

Expected to finish

2024-07-01

Last updated by the study team

2024-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 18 years of age of either gender and any race.
• Provide written informed consent and sign the HIPAA form.
• Be willing and able to follow all instructions and attend all study visits.

You may not qualify if…

• Use of any of the disallowed medications during the washout and study period.

Where it is running

• Vanda Investigational Site — Andover, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.